ArticleFrontiers in cellular and infection microbiology2026
Correlation between MIC of econazole nitrate and clinical response in otomycosis.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Otomycosis is a common superficial fungal infection in otolaryngology, with an increasing incidence that severely affects patients' quality of life. There are regional variations in the distribution of dominant pathogenic fungi. This study was designed to determine the distribution of pathogenic fungi causing otomycosis in the local region, evaluate the Methods: Ear secretion specimens from 196 patients with otomycosis were collected at the Department of Otolaryngology of Zhejiang Provincial Hospital of Chinese Medicine from December 2022 to December 2024 for isolation, culture, and identification of pathogens, along with drug sensitivity testing. Clinical data from 149 patients with complete follow-up records were combined to analyze the correlation between MIC and treatment duration. Results: Among the 196 patients, Conclusion: The pathogenic spectrum of otomycosis in this region is unique, with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.